Sun Life Financial’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,506
Closed -$244K 473
2019
Q3
$244K Buy
6,506
+37
+0.6% +$1.41K 0.06% 167
2019
Q2
$282K Hold
6,469
0.07% 148
2019
Q1
$276K Buy
6,469
+35
+0.5% +$1.57K 0.06% 163
2018
Q4
$288K Buy
6,434
+32
+0.5% +$1.68K 0.06% 154
2018
Q3
$439K Buy
6,402
+40
+0.6% +$2.57K 0.08% 146
2018
Q2
$364K Buy
+6,362
New +$336K 0.05% 154
2016
Q4
Sell
-246
Closed -$9K 503
2016
Q3
$9K Sell
246
-360
-59% -$12.6K ﹤0.01% 97
2016
Q2
$20K Sell
606
-375
-38% -$11.5K ﹤0.01% 120
2016
Q1
$28 Sell
981
-357
-27% -$9.51K ﹤0.01% 154
2015
Q4
$45K Sell
1,338
-434
-24% -$13.5K 0.01% 101
2015
Q3
$50K Sell
1,772
-978
-36% -$34.1K 0.01% 79
2015
Q2
$111K Hold
2,750
0.01% 85
2015
Q1
$135K Hold
2,750
0.01% 86
2014
Q4
$125K Buy
+2,750
New +$108K 0.01% 85

Other funds holding AVNS

Sun Life Financial's AVNS Position: Q4 2019 in Review

Sun Life Financial sold out of Avanos Medical (AVNS) in Q4 2019, closing a stake of 6,506 shares — an estimated $244K sold.

Sun Life Financial first reported a position in AVNS in Q4 2014 and held it in 14 quarters. The position peaked at $439K in Q3 2018. 293 funds tracked by Wall St. Rank hold AVNS as of Q4 2019.

  • Sun Life Financial reported no remaining Avanos Medical position as of Q4 2019 after selling out during the quarter.
  • Sun Life Financial sold 6,506 Avanos Medical shares in Q4 2019, an estimated $244K.
  • Sun Life Financial first reported a position in Avanos Medical in Q4 2014 and held it in 14 quarters.
  • Sun Life Financial's Avanos Medical position peaked at $439K in Q3 2018.
  • 293 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2019.

Based on Sun Life Financial's 13F filing for Q4 2019, filed 10 Feb 2020.